SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements
SEC Accession No. 0000950123-10-033495
Filing Date
2010-04-09
Accepted
2010-04-09 13:03:30
Documents
4
Period of Report
2010-05-26
Filing Date Changed
2010-04-09
Effectiveness Date
2010-04-09

Document Format Files

Seq Description Document Type Size
1 SCHEDULE DEF 14A f55274pdef14a.htm DEF 14A 862832
2 GRAPHIC f55274pf5527400.gif GRAPHIC 4451
3 GRAPHIC f55274pf5527401.gif GRAPHIC 631
4 GRAPHIC f55274pf5527402.gif GRAPHIC 7523
  Complete submission text file 0000950123-10-033495.txt   882101
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-28298 | Film No.: 10741916
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1